Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cinaciguat( BAY582667, BAY58-2667) is a soluble guanosine cyclase activator that can prevent cardiac dysfunction in rat models of type 1 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 8-10 weeks | $ 112.00 | |
25 mg | 8-10 weeks | $ 759.00 | |
50 mg | 8-10 weeks | $ 986.00 | |
100 mg | 8-10 weeks | $ 1,480.00 |
Description | Cinaciguat( BAY582667, BAY58-2667) is a soluble guanosine cyclase activator that can prevent cardiac dysfunction in rat models of type 1 diabetes. |
Targets&IC50 | GC:15 nM (EC50) |
Synonyms | BAY582667, BAY58-2667, BAY 582667, BAY-582667, BAY 58-2667, BAY-58-2667, Cinaciguat HCl |
Molecular Weight | 602.17 |
Formula | C36H40ClNO5 |
CAS No. | 646995-35-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cinaciguat hydrochloride 646995-35-9 BAY582667 BAY58-2667 Cinaciguat Hydrochloride BAY 582667 BAY-582667 BAY 58-2667 BAY-58-2667 Cinaciguat HCl inhibitor inhibit